Amplitude Surgical SA

Paris Stock Exchange AMPLI.PA

Amplitude Surgical SA Price to Sales Ratio (P/S) on February 05, 2025: 1.50

Amplitude Surgical SA Price to Sales Ratio (P/S) is 1.50 on February 05, 2025, a 3.27% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Amplitude Surgical SA 52-week high Price to Sales Ratio (P/S) is 1.55 on October 24, 2024, which is 3.47% above the current Price to Sales Ratio (P/S).
Amplitude Surgical SA 52-week low Price to Sales Ratio (P/S) is 1.19 on May 14, 2024, which is -20.69% below the current Price to Sales Ratio (P/S).
Amplitude Surgical SA average Price to Sales Ratio (P/S) for the last 52 weeks is 1.39.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Paris Stock Exchange: AMPLI.PA

Amplitude Surgical SA

CEO	Mr. Olivier Jallabert
IPO Date	June 26, 2015
Location	France
Headquarters	11, Cours Jacques Offenbach
Employees	416
Sector	Healthcare
Industries Medical Instruments 3D Printing Robotics

Description

Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It offers knee and hip prostheses and implants for the foot and ankle. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, it offers instruments for fitting implants. The company sells its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France.

Key trends

Past 5 years